From New Atlas:
New experimental drug rapidly repairs age-related memory loss and improves mood
A team of Canadian scientists has developed a fascinating new experimental drug that is purported to result in rapid improvements to both mood and memory following extensive animal testing. It's hoped the drug will move to human trials within the next two years.
Gamma-aminobutyric acid (GABA) is a key neurotransmitter, and when altered it can play a role in the development of everything from psychiatric conditions to cognitive degeneration. Benzodiazepines, such as Xanax or Valium, are a class of drugs well known to function by modulating the brain's GABA systems.
This new research describes the development of several new molecules that are structurally based on benzodiazepines, but with small tweaks to enhance their ability to specifically target certain brain areas. The goal was to create a new therapeutic agent that can effectively combat age-related mood and memory alterations caused by disruptions in the GABA systems.
"Currently there are no medications to treat cognitive symptoms such as memory loss that occur in depression, other mental illnesses and aging," says Etienne Sibille, from the Centre for Addiction and Mental Health and lead scientist on the new research.
If this pans out, they should just put it in the water systems like we do with Chlorine and Fluorine. Overall improvement to society.
Leave a comment